As shown in Figures 6(a) and 6(b), after DHA treatment, ROS level in glioma cells with both TUG1 and MAZ overexpression was lower than TUG1 overexpression alone, but higher than MAZ overexpression alone. This evidence concerns the gene MAZ and central nervous system cancer.